Blood Work for Ankylosing Spondylitis
HLA-B27 testing is the most valuable blood test for suspected ankylosing spondylitis, with 90% sensitivity and 90% specificity, and should be ordered for all patients with chronic inflammatory back pain with onset before age 45. 1
Primary Laboratory Tests
HLA-B27: The cornerstone laboratory test for AS screening
Inflammatory markers:
Interpretation and Clinical Context
When evaluating a patient with suspected ankylosing spondylitis:
HLA-B27 positive result: Significantly increases likelihood of AS (likelihood ratio of 9) 2
- Most valuable in patients with inflammatory back pain starting before age 45 that has lasted >3 months
- Only 10% of AS patients are HLA-B27 negative 1
Inflammatory markers (ESR/CRP):
Important Considerations
No single blood test can diagnose AS - diagnosis requires a combination of clinical, laboratory, and imaging findings 1
Clinical criteria for referral to rheumatologist when AS is suspected:
- Back pain starting before age 45 lasting >3 months, plus
- At least 4 of: back pain before age 35, night pain, buttock pain, improvement with movement/NSAIDs, family history of spondyloarthritis, current/previous arthritis/enthesitis/psoriasis
- OR 3 of the above criteria plus positive HLA-B27 1
Imaging remains essential: Radiographs of the sacroiliac joints are the initial imaging modality of choice 2, 3
- If x-rays are negative but clinical suspicion remains high, HLA-B27 testing is indicated 3
Monitoring Disease Activity
- Regular-interval monitoring of CRP/ESR is conditionally recommended to assess response to treatment 2, 1
- Use of validated AS disease activity measures is conditionally recommended at regular intervals 2
Remember that while blood tests are valuable tools in the diagnostic process, they must be interpreted in the context of clinical presentation and imaging findings. HLA-B27 testing provides the highest diagnostic utility among laboratory tests for AS screening.